about
Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infectionsInsights into Newer Antimicrobial Agents Against Gram-negative BacteriaCarbapenem resistance: overview of the problem and future perspectivesClinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.Establishment of a Simple and Quick Method for Detecting Extended-Spectrum β-Lactamase (ESBL) Genes in BacteriaCompatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections.Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration.Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Bacterial fatty acid metabolism in modern antibiotic discovery.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.Ceftazidime-avibactam for the treatment of complicated intra-abdominal infections.WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.Post-hemodialysis dosing of 1 vs. 2 g of ceftazidime in anuric end-stage renal disease patients on low-flux dialysis and its pharmacodynamic implications on clinical use.Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex speciesWhat is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?[Rational antibiotic treatment of mediastinitis].High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coliActivity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015-16.In Vitro Activity of Ceftazidime-Avibactam Against Isolates from Patients in a Phase 3 Clinical Trial for the Treatment of Complicated Intra-Abdominal Infections.Epidemiology of Carbapenem-Resistant Enterobacteriaceae at a Long-term Acute Care Hospital
P2860
Q26747429-443B57A5-4968-4BA2-80AE-7E43B5D18B36Q26751255-0AE8A999-E9BC-481B-BAA2-4C9D44C794A3Q26767081-F04D4968-A196-4783-8B92-774D5AF5795DQ33816207-0B9F48B5-9E23-4985-9759-E3C3B6349CD4Q37262542-11456FD2-3290-4169-AF0E-326A7AE60298Q38691351-427AD729-46FA-4662-B21A-0F780DDE97F5Q38797485-D4F98513-B28C-470C-A72D-9A4BFB5EAB1EQ38833630-AE08F6D1-7ED2-4152-9334-AB4A3354471BQ38901844-E6D8043C-4DFA-45A1-92B1-E3CEBE84E8DAQ38944862-31CF2E84-A1B0-49E5-978F-825CB4FF55AEQ38958278-0F313393-FB5B-471B-A561-AAAE0D25A272Q38964523-7AA9E3F2-FB98-470D-888D-2C4D5E1B0DF0Q38981397-FB25123C-F76F-466B-ABAE-6B973A3EE81CQ38985065-A2E3B8EF-7DFA-4C6A-8C78-2ACB0420DC4DQ40282005-B9C343FA-479D-4E52-B04A-E16666128A99Q40408837-77C6059D-6F14-4AC9-BEA2-19417EA26E74Q40432033-6DC8800D-727B-4934-AE83-AE080E7E43B6Q40550507-E00A6A3C-2D64-4858-8DED-CDFAD6FC495AQ40669289-55DD15E5-1014-410F-8976-370A6F125C7DQ42102553-2417B97F-851C-4A51-8D28-C7B27F886F19Q42319609-474838ED-7F5F-4C0C-AB28-F5F11543F734Q47330235-AC3D4112-558B-4183-8546-470569C93508Q52568634-34D5F2BD-0507-4A06-9BB0-3FB3C9DBB855Q57298172-D6A11D70-0DEF-4240-92CB-8BBCF59F0E88
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The β-Lactams Strike Back: Ceftazidime-Avibactam
@ast
The β-Lactams Strike Back: Ceftazidime-Avibactam
@en
The β-Lactams Strike Back: Ceftazidime-Avibactam
@nl
type
label
The β-Lactams Strike Back: Ceftazidime-Avibactam
@ast
The β-Lactams Strike Back: Ceftazidime-Avibactam
@en
The β-Lactams Strike Back: Ceftazidime-Avibactam
@nl
prefLabel
The β-Lactams Strike Back: Ceftazidime-Avibactam
@ast
The β-Lactams Strike Back: Ceftazidime-Avibactam
@en
The β-Lactams Strike Back: Ceftazidime-Avibactam
@nl
P2093
P2860
P3181
P356
P1433
P1476
The β-Lactams Strike Back: Ceftazidime-Avibactam
@en
P2093
Evan J Zasowski
Jeffrey M Rybak
Michael J Rybak
P2860
P304
P3181
P356
10.1002/PHAR.1622
P407
P577
2015-08-01T00:00:00Z